Skip to main content
. 2012 Mar 7;205(8):1203–1213. doi: 10.1093/infdis/jis102

Figure 6.

Figure 6.

In vivo bromodeoxyuridine (BrdU) labeling and flow cytometry. Four animals from each group were injected with BrdU (10 mg/kg body weight) as described elsewhere [28], prior to infection (A) and 4–5 weeks postinfection (B). Blood was collected 24 hours after BrdU inoculation. The percentages of BrdU-positive cells in CD14+ monocytes were analyzed by flow cytometry as described elsewhere [28].